Mastermind Session: Advancing rhPSMA from Early Clinical Promise to Registrational Success: Overcoming the Phase I–III Bottleneck
Targeted Radiopharmaceuticals Summit EU 2026 · 3 December 2026 · 14:30
Mastermind Session: Advancing rhPSMA from Early Clinical Promise to Registrational Success: Overcoming the Phase I–III Bottleneck was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 3 December 2026 in London.